Total Funding
31
Total FundingPost-IPO Equity raised
Growth Score in past quarter
pts
Heat Score 31 in past quarter
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
206295
At GTx, They focus on the development of small molecules that selectively modulate the effects of certain hormones produced by the body.
Acquired by 
Oncternal Therapeutics
- Mitchell Steiner: Founder, CEO and Vice Chairman of Board of Directors
Marc S. Hanover: President and Chief Operating Officer
About the Company
GTx, Inc. is a company of pioneering and driven individuals who are delivering better medicines with new science through established pathways.


